Financial Summary (All financials)
In millions, except per share items | Sep-24-22 | Sep-25-21 | Sep-26-20 | Sep-28-19 | Sep-29-18 | Sep-30-17 | Sep-24-16 | Sep-26-15 |
Revenues | 394,328.0 | 365,817.0 | 274,515.0 | 260,174.0 | 265,595.0 | 229,234.0 | 215,639.0 | 233,715.0 |
Revenue growth | 7.8% | 33.3% | 5.5% | -2.0% | 15.9% | 6.3% | -7.7% | 27.9% |
Cost of goods sold | 223,546.0 | 212,981.0 | 169,559.0 | 161,782.0 | 163,756.0 | 141,048.0 | 131,376.0 | 140,089.0 |
Gross profit | 170,782.0 | 152,836.0 | 104,956.0 | 98,392.0 | 101,839.0 | 88,186.0 | 84,263.0 | 93,626.0 |
Gross margin | 43.3% | 41.8% | 38.2% | 37.8% | 38.3% | 38.5% | 39.1% | 40.1% |
Selling, general and administrative | 25,094.0 | 21,973.0 | 19,916.0 | 18,245.0 | 16,705.0 | 15,261.0 | 14,194.0 | 14,329.0 |
Research and development | 26,251.0 | 21,914.0 | 18,752.0 | 16,217.0 | 14,236.0 | 11,581.0 | 10,045.0 | 8,067.0 |
EBITA | 119,437.0 | 108,949.0 | 66,288.0 | 63,930.0 | 70,898.0 | 61,344.0 | 60,024.0 | 72,530.0 |
EBITA margin | 30.3% | 29.8% | 24.1% | 24.6% | 26.7% | 26.8% | 27.8% | 31.0% |
Amortization of intangibles | | | | | | | | 1,300.0 |
EBIT | 119,437.0 | 108,949.0 | 66,288.0 | 63,930.0 | 70,898.0 | 61,344.0 | 60,024.0 | 71,230.0 |
EBIT margin | 30.3% | 29.8% | 24.1% | 24.6% | 26.7% | 26.8% | 27.8% | 30.5% |
Pre-tax income | 119,103.0 | 109,207.0 | 67,091.0 | 65,737.0 | 72,903.0 | 64,089.0 | 61,372.0 | 72,515.0 |
Income taxes | 19,300.0 | 14,527.0 | 9,680.0 | 10,481.0 | 13,372.0 | 15,738.0 | 15,685.0 | 19,121.0 |
Tax rate | 16.2% | 13.3% | 14.4% | 15.9% | 18.3% | 24.6% | 25.6% | 26.4% |
Net income | 99,803.0 | 94,680.0 | 57,411.0 | 55,256.0 | 59,531.0 | 48,351.0 | 45,687.0 | 53,394.0 |
Net margin | 25.3% | 25.9% | 20.9% | 21.2% | 22.4% | 21.1% | 21.2% | 22.8% |
|
Diluted EPS | $6.11 | $5.61 | $3.28 | $11.89 | $11.91 | $9.21 | $8.31 | $9.22 |
Shares outstanding (diluted) | 16,325.8 | 16,864.9 | 17,528.2 | 4,648.9 | 5,000.1 | 5,251.7 | 5,500.3 | 5,793.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|